Advanced search

336 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Motion for Asset Sale Approved for SVB Financial Group	30/05	CI
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio	25/05	GL
Axon Enterprise, Inc. (NasdaqGS : AXON) agreed to acquire Dedrone.	06/05	CI
Motion for Asset Sale Filed by SVB Financial Group	02/05	CI
Laboratory of America : Corporate Responsibility Report (Labcorp_Corporate_Responsibility_Report_2023_Final_v3_1)	09/04	PU
Laboratory of America : Corporate Responsibility Report (Labcorp_Corporate_Responsibility_Report_2023_Final_v3_2)	09/04	PU
Laboratory of America : 2023 Corporate Responsibility Report	09/04	PU
Cintas Corporation Announces Fiscal 2024 Third Quarter Results	27/03	BU
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook	20/03	GL
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing	05/03	BU
Valeo atteint ses objectifs 2023 et se fixe pour objectif d’augmenter de plus de 60 % son résultat d’exploitation et sa génération de cash entre 2023 et 2025	29/02	GL
Pros Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	09/02	BU
BlackRock Income and Growth Investment Trust Plc - Final Results	21/12	PR
Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates	09/11	GL
Annovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s Patients	02/11	BU
FDA approves Novartis Cosentyx® as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade	01/23/01	GL
Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023	18/23/18	PR
Itaú Unibanco S A : ITAÚ UNIBANCO - REFERENCE FORM - Form 6-K	16/23/16	PU
Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa	12/23/12	PR
UCB : Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa	12/23/12	PU
Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates	21/23/21	GL
Bed Bath & Beyond : UNITED STATES BANKRUPTCY COURT - Form 8-K	14/23/14	PU
Transcript : NCR Corporation - Analyst/Investor Day	05/23/05
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome	01/23/01	BU
Transcript : Daimler Truck Holding AG - Analyst/Investor Day	11/23/11
NET Power, LLC completed the acquisition of Rice Acquisition Corp. II from Rice Acquisition Sponsor II LLC and others in a reverse merger transaction.	08/23/08	CI
Novartis : receives European approval for Cosentyx® as first and only IL-17A inhibitor for hidradenitis suppurativa	01/23/01	PU
Transcript : SAP SE - Shareholder/Analyst Call	16/23/16
ARS Pharmaceuticals : FDA has posted an Addendum to Briefing Document on its website that was circulated to members of the AdCom - Form 8-K	09/23/09	PU
Lazard Ltd Reports First-Quarter 2023 Results	28/23/28	BU
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa	26/23/26	GL
Transcript : ASML Holding N.V. - Shareholder/Analyst Call	26/23/26
Natura & S A : 1. Minutes of the Board of Directors’ Meeting Held on March 26, 2023 - Form 6-K	29/23/29	PU
Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®	04/23/04	GL
BlackRock Income and Growth Investment Trust Plc - Final Results and Final Dividend	02/23/02	PR
Mainz Biomed Provides Year-End 2022 Corporate Review	03/23/03	GL
Victoria's Secret & Co. completed the acquisition of AdoreMe, Inc. from Ventech SA and others.	30/22/30	CI
Keppel Infrastructure Trust and Keppel Renewable Investments Pte. Ltd acquired 25% stake in Borkum Riffgrund from Gulf International Holding Pte. Ltd for €305 million.	22/22/22	CI
NET Power, LLC signed a non-binding letter of intent to acquire Rice Acquisition Corp. II from Rice Acquisition Sponsor II LLC and others for $1.4 billion in a reverse merger transaction.	14/22/14	CI
Transcript : XPS Pensions Group plc, H1 2023 Earnings Call, Dec 07, 2022	07/22/07
Transcript : ASML Holding N.V. - Analyst/Investor Day	11/22/11
Victoria's Secret & Co. entered into a definitive agreement to acquire AdoreMe, Inc. from Ventech SA and others for approximately $770 million.	01/22/01	CI
Lazard Ltd Reports Third-Quarter and Nine-Month 2022 Results	27/22/27	BU
Transcript : Nexans S.A., Q3 2022 Earnings Call, Oct 26, 2022	26/22/26
XPO Logistics : Regulation FD Presentation - Form 8-K	20/22/20	PU
Cintas : 2022 Proxy Card	15/22/15	PU
Transcript : Roche Holding AG - Special Call	12/22/12
Keppel Infrastructure Trust and Keppel Renewable Investments Pte. Ltd has entered into a sale and purchase agreement to acquire 25% stake in Borkum Riffgrund from Gulf International Holding Pte. Ltd for €305 million.	11/22/11	CI
Itaú Unibanco S A : 2Q 22 Management discussion & analysis and complete financial statements Second quarter of 2022 - Form 6-K	10/22/10	PU
Itaú Unibanco S A : Reference Form itau Unibanco Holding S.A - Form 6-K	09/22/09	PU

No results for this search

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer